Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2007.03.024
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2007
Authors
Publisher
Elsevier BV
Available in full text
May 1, 2007
Elsevier BV